167 related articles for article (PubMed ID: 16455942)
1. Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays.
Zouhair S; Roussin-Bretagne S; Moreau A; Brunet S; Laperche S; Maniez M; Barin F; Harzic M
J Clin Microbiol; 2006 Feb; 44(2):662-5. PubMed ID: 16455942
[TBL] [Abstract][Full Text] [Related]
2. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
3. Diversity of the immunodominant epitope of gp41 of HIV-1 subtype O and its validity for antibody detection.
Eberle J; Loussert-Ajaka I; Brust S; Zekeng L; Hauser PH; Kaptue L; Knapp S; Damond F; Saragosti S; Simon F; Gürtler LG
J Virol Methods; 1997 Aug; 67(1):85-91. PubMed ID: 9274821
[TBL] [Abstract][Full Text] [Related]
4. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots.
Barin F; Meyer L; Lancar R; Deveau C; Gharib M; Laporte A; Desenclos JC; Costagliola D
J Clin Microbiol; 2005 Sep; 43(9):4441-7. PubMed ID: 16145089
[TBL] [Abstract][Full Text] [Related]
6. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
[TBL] [Abstract][Full Text] [Related]
7. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
Ugen KE; Goedert JJ; Boyer J; Refaeli Y; Frank I; Williams WV; Willoughby A; Landesman S; Mendez H; Rubinstein A
J Clin Invest; 1992 Jun; 89(6):1923-30. PubMed ID: 1601999
[TBL] [Abstract][Full Text] [Related]
8. Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france.
Damond F; Apetrei C; Robertson DL; Souquière S; Leprêtre A; Matheron S; Plantier JC; Brun-Vézinet F; Simon F
Virology; 2001 Feb; 280(1):19-30. PubMed ID: 11162815
[TBL] [Abstract][Full Text] [Related]
9. Phylogeny of HIV type 1 group O isolates based on env gene sequences.
Mas A; Quiñones-Mateu ME; Domingo E; Soriano V
AIDS Res Hum Retroviruses; 1999 May; 15(8):769-73. PubMed ID: 10357472
[No Abstract] [Full Text] [Related]
10. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
11. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
[TBL] [Abstract][Full Text] [Related]
12. Synthetic peptide ELISAs for detection of and discrimination between group M and group O HIV type 1 infection.
Mauclère P; Damond F; Apetrei C; Loussert-Ajaka I; Souquière S; Buzelay L; Dalbon P; Jolivet M; Mony Lobe M; Brun-Vézinet F; Simon F; Barin F
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):987-93. PubMed ID: 9264285
[TBL] [Abstract][Full Text] [Related]
13. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus serotyping on dried serum spots as a screening tool for the surveillance of the AIDS epidemic.
Barin F; Plantier JC; Brand D; Brunet S; Moreau A; Liandier B; Thierry D; Cazein F; Lot F; Semaille C; Desenclos JC
J Med Virol; 2006; 78 Suppl 1():S13-8. PubMed ID: 16622871
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
Mitchell WM; Ding L; Gabriel J
AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
[TBL] [Abstract][Full Text] [Related]
16. Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission.
Wang XP; Oyaizu N; Pahwa S
Pediatr Res; 1995 Sep; 38(3):384-9. PubMed ID: 7494664
[TBL] [Abstract][Full Text] [Related]
17. B cell antigenic site mapping of HIV-1 glycoproteins.
Neurath AR
Chem Immunol; 1993; 56():34-60. PubMed ID: 8452653
[No Abstract] [Full Text] [Related]
18. Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope.
Palacios-Rodríguez Y; Gazarian T; Rowley M; Majluf-Cruz A; Gazarian K
J Microbiol Methods; 2007 Feb; 68(2):225-35. PubMed ID: 17046088
[TBL] [Abstract][Full Text] [Related]
19. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
[TBL] [Abstract][Full Text] [Related]
20. Chimeric synthetic peptide as antigen for immunodiagnosis of HIV-1 infection.
Hernández M; Pozo L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 May; 272(1):259-62. PubMed ID: 10872836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
